Last reviewed · How we verify
MUC1-gene-DC-CTL — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
MUC1-gene-DC-CTL (MUC1-gene-DC-CTL) — Beijing Doing Biomedical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MUC1-gene-DC-CTL TARGET | MUC1-gene-DC-CTL | Beijing Doing Biomedical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MUC1-gene-DC-CTL CI watch — RSS
- MUC1-gene-DC-CTL CI watch — Atom
- MUC1-gene-DC-CTL CI watch — JSON
- MUC1-gene-DC-CTL alone — RSS
Cite this brief
Drug Landscape (2026). MUC1-gene-DC-CTL — Competitive Intelligence Brief. https://druglandscape.com/ci/muc1-gene-dc-ctl. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing